【摘 要】
：
A resurging interest in targeted covalent inhibitors(TCIs)focus on compounds capable of irreversibly reacting with nucleophilic amino acids in a druggable target.p97 is an emerging protein target for cancer therapy,viral infections and neurodegenerative d
【机 构】
：
State Key Laboratory of Bioactive Substances and Functions of Natural Medicines and Beijing Key Labo
论文部分内容阅读
A resurging interest in targeted covalent inhibitors(TCIs)focus on compounds capable of irreversibly reacting with nucleophilic amino acids in a druggable target.p97 is an emerging protein target for cancer therapy,viral infections and neurodegenerative diseases.Extensive efforts were devoted to the development of p97 inhibitors.The most promising inhibitor of p97 was in phase 1 clinical trials,but failed due to the off-target-induced toxicity,suggesting the selective inhibitors of p97 are highly needed.We report herein a new type of TCIs(i.e.,FL-18)that showed proteome-wide selectivity towards p97.Equipped with a Michael acceptor and a basic imidazole,FL-18 showed potent inhibition towards U87MG tumor cells,and in proteome-wide profiling,selectively modified endogenous p97 as confirmed by in situ fluorescence scanning,label-free quantitative proteomics and functional validations.FL-18 selectively modified cysteine residues located within the D2 ATP site of p97.This covalent labeling of cysteine residue in p97 was verified by LC-MS/MS-based site-mapping and site-directed mutagenesis.Further structure-activity relationship(SAR)studies with FL-18 analogs were established.Collectively,FL-18 is the first known small-molecule TCI capable of covalent engagement of p97 with proteome-wide selectivity,thus providing a promising scaffold for cancer therapy.
其他文献
目的:研究曲匹地尔的有关物质,并建立高效液相色谱法测定有关物质.方法:采用SinoChrom ODS-BP (200 mm×4.6 mm,5μm)色谱柱,以甲醇、乙腈和磷酸盐缓冲液为流动相,等度洗脱,流速1.0 mL·min-,检测波长205 nm.采用校正因子计算已知杂质和其它杂质的含量,并对降解试验产生杂质采用LC-MS进行确认,确证降解产物结构.结果:曲匹地尔与强制破坏产生的降解产物均分离良好;曲匹地尔杂质A和杂质B定量下限分别为0.089 ng和0.13 ng,检测下限分别为0.029 ng和0.
目的:对气相色谱法测定棕榈酸与硬脂酸进行改进,建立无衍生化气相色谱法测定药用胶塞中棕榈酸与硬脂酸的可提取量和迁移量的分析方法.方法:采用DB-FFAP毛细管色谱柱(30 m×0.25 mm×0.25 μm);程序升温:初始温度为100℃,保持1 min,以60℃·min-1的速率升至230℃,保持20 min;进样口温度250℃;氢火焰离子化检测器,检测器温度250℃;分流比10∶1;载气流速为1.0 mL·min-1.结果:棕榈酸和硬脂酸线性范围分别为0.8844 ～88.44μg·mL-1 (r2 =
目的:采用核磁共振法和液相色谱-质谱对氯唑沙宗5个未知杂质进行结构确证,并建立有关物质检查的方法.方法:采用制备色谱分离提纯获得高纯度的杂质E,运用HPLC-MS、1H-NMR、13C-NMR、HSQC和HMBC等技术手段对5个杂质进行结构确证.有关物质检查采用Waters XBridge C18柱(250 mm×4.6 mm,5μm),流动相为10 mmol·L-1醋酸铵溶液-乙腈,梯度洗脱,流速为1.0 mL·min-1,检测波长为220 nm,柱温为30℃.结果:通过光谱数据分析,鉴定出氯唑沙宗原料
目的:运用信息熵赋权法和星点设计-效应面法优选四妙勇安汤发酵物的片剂处方.方法:在单因素实验基础上,以颗粒成型率、流动性(cot值)为评价指标,确定以乳糖为填充剂,95％乙醇作为黏合剂,淀粉、聚维酮为崩解剂,硬脂酸镁为助流剂;以加醇量、助流剂使用量、乳糖和药粉的比例、淀粉与聚维酮的比例为影响因素,以吸湿率、弹性复原率、硬度和脆碎度作为响应指标,采用信息熵赋权法结合星点设计-效应面法优选四妙勇安汤发酵物的片剂处方.结果:四妙勇安汤发酵物的片剂最优处方工艺为乳糖和药粉的总量为15 g,95％乙醇的加入量为3.
目的:对吸入用乙酰半胱氨酸溶液药包材的质量现状进行分析,为保障其质量提供更合理的依据.方法:对包装吸入用乙酰半胱氨酸溶液的玻璃安瓿的平均线热膨胀系数、折断力、内表面的侵蚀程度、元素的迁移、透光率以及制剂中有关物质进行研究.结果:A制剂(原研药)、B制剂、C制剂均采用棕色中硼硅玻璃安瓿作为包装,D制剂采用无色低硼硅玻璃安瓿作为包装.A制剂安瓿的折断力小于B、C、D制剂.总体来说,中硼硅玻璃安瓿与药物的相容性好于低硼硅玻璃安瓿;棕色玻璃包装制剂的有关物质经过光照试验后几乎没有变化,无色玻璃的各个杂质均有一定程
目的:对进口精蛋白锌重组赖脯胰岛素混合注射液进行质量分析.方法:对2018 ～2020年经苏州口岸进口的129批(722件)精蛋白锌重组赖脯胰岛素混合注射液的有关物质、苯酚和间甲酚、可溶性赖脯胰岛素、含量、锌、高分子蛋白质、pH等质量参数进行统计分析,并对结果进行趋势分析.结果:精蛋白锌重组赖脯胰岛素混合注射液(25R)36批352件,占48.8％,精蛋白锌重组赖脯胰岛素混合注射液(50R)93批370件,占51.2％.722件精蛋白锌重组赖脯胰岛素混合注射液关键参数检测结果主要位于平均值±2SD区间.苯
Tumor-targeted immunotherapy is a remarkable breakthrough,offering the inimitable advan-tage of specific tumoricidal effects with reduced immune-associated cytotoxicity.However,existing plat-forms suffer from low efficacy,inability to induce strong immuno
Ferroptosis is a non-apoptotic regulated cell death caused by iron accumulation and subse-quent lipid peroxidation.Currently,the therapeutic role of ferroptosis on cancer is gaining increasing in-terest.Baicalin an active component in Scutellaria baicalen
目的:探究1,25-二羟基维生素D3对急性重症胰腺炎模型大鼠淋巴细胞凋亡及Toll样受体4和9表达的影响.方法:选取90只大鼠,随机分为:正常对照组(A)、模型对照组(B)、低剂量组(C)、中剂量组(D)、高低剂量组(E)和阳性药对照组(F),每组15只.除A组外,其余各组使用牛磺胆酸钠制成急性重症胰腺炎大鼠模型;C、D、E组分别腹腔注射2.5、5、10 μg·kg-1的1,25-二羟基维生素D3,F组皮下注射40 mg· kg.1的奥曲肽;采用HE染色观察胰腺组织病理损伤,免疫组化检测胰腺组织的Casp
目的:建立一种气相色谱-质谱联用仪(GC-MS)技术-同位素内标法(内标物:四氢大麻酚-D3,THC-D3)同时测定汉麻中大麻二酚(cannabidiol,CBD)、四氢大麻酚(tetrahydrocannabinol,THC)和大麻酚(cannabinol,CBN)3个有效成分的含量,并探讨不同产地汉麻中其含量特征及化学表型.方法:用甲醇超声提取样品中目标成分,离心后制备样品溶液.利用GC-MS,选定合理的色谱、质谱条件,运用同位素内标法建立测定汉麻中CBD、THC、CBN 3个成分含量的定性、定量分析